Definitive Contract 75D30120C08170
Award Date
5/12/20
Potential Completion Date
5/11/24
Potential Value
$46M
Federal Agency
CDC Pittsburgh
Awardee
Vitalant
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the prime contractor, Vitalant (doing business as Vitalant Research Institute), a non-profit organization. The $4,856,660.60 firm fixed price purchase order is for a study assessing the predictive value of a panel of questions to identify recent HIV infection in men who have sex with men (MSM) interested in donating blood. The prime contractor, Vitalant, is collaborating with two...
This is a $371,292 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the American Red Cross. The contract is for conducting a study to estimate the odds of SARS-CoV-2 seropositivity among blood donors during the COVID-19 pandemic. The American Red Cross, a non-profit humanitarian organization, is the prime contractor and will perform the work at a location in Derwood, Maryland. This contract is not set aside for any specific business...
This is a $4,595,658.07 Definitive Contract awarded by the Food and Drug Administration (FDA) to Vitalant, a nonprofit organization, for the Transfusion-Transmissible Infections Monitoring System (TTIMS) Laboratory and Risk Factor Coordinating Center (LRCC) Services. The contract's primary objectives are to coordinate the collection of risk factor data, integrate data and surveillance information, evaluate and monitor risk factors, and conduct specialized testing and analysis related to HIV,...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to Vitalant, a non-profit organization, for ZIKV/DENV/CHIKV & ZIKA TESTING ON SERUM SAMPLES. The contract is a firm fixed-price purchase order valued at $24,600.00, with a completion date of May 12, 2020. The contract does not have a set-aside designation. Vitalant, through its research division Vitalant Research Institute (VRI),...
This federal contract was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization that provides blood products and conducts research related to transfusion medicine. The contract, titled "REDS-III" (Recipient Epidemiology and Donor Evaluation Study - III), has a ceiling value of $8,847,513.18 and a period of performance ending on December 31, 2019. The contract does not have a set-aside...
This is a $8,446,747.46 federal delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to Vitalant, a non-profit organization. The contract is for the REDS-IV-P - Center for Transfusion Laboratory Studies (CTLS), Phase 1, which involves necessary testing and serving as the biospecimen repository for the REDS-IV-P program. The University of Colorado-Denver is a major subcontractor on this contract, responsible...
This is a $493,905.79 delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute to The Institute For Transfusion Medicine, doing business as Vitalant Research Institute (a division of the nonprofit organization Vitalant). The order is for the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) - Phase 3 - Domestic Site and has a completion date of December 31, 2019. The contract type is Cost No...
The Centers for Disease Control and Prevention awarded a $2.8 million firm fixed price contract to Laboratory Corporation of America, operating as Labcorp, to provide residual blood specimen collection and SARS-CoV-2 serology testing services under the Multistate Assessment of SARS-CoV-2 Seroprevalence study. Labcorp will collect approximately 33,800 residual sera samples per month from all 50 states, Washington D.C. and Puerto Rico, distributed by age, and test for SARS-CoV-2 nucleocapsid...
This federal contract award, with an ID of 75N92019D00034|75N92024F00001, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the prime contractor Vitalant, a non-profit organization. The contract, valued at $2,104,121.00, is for the REDS-IV-P DOMESTIC HUBS project and does not have a set-aside designation. Vitalant Research Institute (VRI), the research arm of Vitalant, is the prime contractor. VRI has established itself as a key federal partner, providing...
This federal contract award is for the REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2 project, awarded by the National Heart Lung and Blood Institute (NHLBI) to the prime contractor, Vitalant Research Institute (VRI), a nonprofit organization. The $4,908,528.00 cost-type delivery order contract has a completion date of March 31, 2025. VRI, the research arm of the nonprofit blood services provider Vitalant, will conduct the study in collaboration with the University of...